SA52 Assessing Missing Antineoplastic Therapy Prior to Electronic Health Record (EHR)-Derived First Line of Therapy after Advanced Non-Small Cell Lung Cancer (ANSCLC) Diagnosis
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2268
https://www.valueinhealthjournal.com/article/S1098-3015(23)02368-9/fulltext
Title :
SA52 Assessing Missing Antineoplastic Therapy Prior to Electronic Health Record (EHR)-Derived First Line of Therapy after Advanced Non-Small Cell Lung Cancer (ANSCLC) Diagnosis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02368-9&doi=10.1016/j.jval.2023.03.2268
First page :
Section Title :
Open access? :
No
Section Order :
11589